You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博瑞医药(688166.SH)拟斥3.5亿人币投建海外高端制剂药品生产项目
阿思达克 12-10 07:34

博瑞医药(688166.SH)公布,公司拟投资建设海外高端制剂药品生产项目,项目总投资约3.48亿元人民币(下同),拟通过自有资金以及向银行项目贷款方式实施,其中银行贷款不超过2.5亿元。

该项目建设期为两年,实施主体为博瑞生物医药(苏州)股份有限公司,项目位於苏州工业园区。

公司表示,该项目将用於符合美国FDA、欧盟cGMP标准的注射剂产品生产,对应的注射剂产品主要涉及抗真菌药物、抗血栓药物、补铁剂药物和抗肿瘤药物等,拥有广阔的市场前景。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account